January 2023
1. COUGHLAN G, Plumb W, Zhukovsky P, Aung MH, et al
   Vestibular contribution to path integration deficits in 'at-genetic-risk' for Alzheimer's disease.
   PLoS One. 2023;18:e0278239.
   

   >> Share

   
   
2. CHANG HT, Chiu PY
   Development of a simple screening tool for determining cognitive status in Alzheimer's disease.
   PLoS One. 2023;18:e0280178.
   

   >> Share

   
   
3. DEBNATH S, Sharma D, Chaudhari SY, Sharma R, et al
   Wheat ergot fungus-derived and modified drug for inhibition of intracranial aneurysm rupture due to dysfunction of TLR-4 receptor in Alzheimer's disease.
   PLoS One. 2023;18:e0279616.
   

   >> Share

   
   
4. SHAFIGHI K, Villeneuve S, Rosa Neto P, Badhwar A, et al
   Social isolation is linked to classical risk factors of Alzheimer's disease-related dementias.
   PLoS One. 2023;18:e0280471.
   

   >> Share

   
   
5. CHATTERJEE S, Sealey M, Ruiz E, Pegasiou CM, et al
   Age-related changes in tau and autophagy in human brain in the absence of neurodegeneration.
   PLoS One. 2023;18:e0262792.
   

   >> Share

   
   
6. ZHENG X, Cawood J, Hayre C, Wang S, et al
   Computer assisted diagnosis of Alzheimer's disease using statistical likelihood-ratio test.
   PLoS One. 2023;18:e0279574.
   

   >> Share

   
   
7. JETT S, Dyke JP, Boneu Yepez C, Zarate C, et al
   Effects of sex and APOE epsilon4 genotype on brain mitochondrial high-energy phosphates in midlife individuals at risk for Alzheimer's disease: A 31Phosphorus MR spectroscopy study.
   PLoS One. 2023;18:e0281302.
   

   >> Share

   
   
8. LANDES SD, Finan JM, Turk MA
   Reporting Down syndrome on the death certificate for Alzheimer disease/unspecified dementia deaths.
   PLoS One. 2023;18:e0281763.
   

   >> Share

   
   
9. SOREQ L, Bird H, Mohamed W, Hardy J, et al
   Single-cell RNA sequencing analysis of human Alzheimer's disease brain samples reveals neuronal and glial specific cells differential expression.
   PLoS One. 2023;18:e0277630.
   

   >> Share

   
   
10. TIAN Y, Kuruvilla MV, Park M
    The use of virtual reality in screening for preclinical Alzheimer's disease: A scoping review protocol.
    PLoS One. 2023;18:e0282436.
    

    >> Share

    
    
11. GARCIA MANRIQUEZ BA, Papapanagiotou JA, Strysick CA, Green EH, et al
    Nanoparticulate air pollution disrupts proteostasis in Caenorhabditis elegans.
    PLoS One. 2023;18:e0275137.
    

    >> Share

    
    
12. KARAMACOSKA D, Chan DKY, Leung I, Liu JX, et al
    Study protocol for a phase III randomised controlled trial of Sailuotong (SLT) for vascular dementia and Alzheimer's disease with cerebrovascular disease.
    PLoS One. 2023;18:e0265285.
    

    >> Share

    
    
13. SHOBEIRI P, Alilou S, Jaberinezhad M, Zare F, et al
    Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer's disease (AD): A systematic review and meta-analysis.
    PLoS One. 2023;18:e0281784.
    

    >> Share

    
    
14. LI Y, Liu H, Li R
    Study of Bayesian variable selection method on mixed linear regression models.
    PLoS One. 2023;18:e0283100.
    

    >> Share

    
    
15. LEE LH, Wu SC, Ho CF, Liang WL, et al
    White matter hyperintensities in cholinergic pathways may predict poorer responsiveness to acetylcholinesterase inhibitor treatment for Alzheimer's disease.
    PLoS One. 2023;18:e0283790.
    

    >> Share

    
    
16. MRAZ H, Tong CY, Liu KPY
    Semantic-based memory-encoding strategy and cognitive stimulation in enhancing cognitive function and daily task performance for older adults with mild cognitive impairment: A pilot non-randomised cluster controlled trial.
    PLoS One. 2023;18:e0283449.
    

    >> Share

    
    
17. AMORIM IS, Challal S, Cistarelli L, Dorval T, et al
    A seeding-based neuronal model of tau aggregation for use in drug discovery.
    PLoS One. 2023;18:e0283941.
    

    >> Share

    
    
18. FAISAL M, Aid J, Nodirov B, Lee B, et al
    Preclinical trials in Alzheimer's disease: Sample size and effect size for behavioural and neuropathological outcomes in 5xFAD mice.
    PLoS One. 2023;18:e0281003.
    

    >> Share

    
    
19. BAKER E, Leonenko G, Schmidt KM, Hill M, et al
    What does heritability of Alzheimer's disease represent?
    PLoS One. 2023;18:e0281440.
    

    >> Share

    
    
20. GIRGIN M, Isik S, Kantarci-Carsibasi N
    Proposing novel natural compounds against Alzheimer's disease targeting acetylcholinesterase.
    PLoS One. 2023;18:e0284994.
    

    >> Share

    
    
21. BAUZA M, Krstulovic M, Krupic J
    Unsupervised, frequent and remote: A novel platform for personalised digital phenotyping of long-term memory in humans.
    PLoS One. 2023;18:e0284220.
    

    >> Share

    
    
22. ALATRANY AS, Khan W, Hussain A, Al-Jumeily D, et al
    Wide and deep learning based approaches for classification of Alzheimer's disease using genome-wide association studies.
    PLoS One. 2023;18:e0283712.
    

    >> Share

    
    
23. SHEPHERD-BANIGAN M, Miller KEM, Hastings SN, Schleiden LJ, et al
    Use of high cost care among Veterans with comorbid mental illness and Alzheimer's Disease and related dementias.
    PLoS One. 2023;18:e0282071.
    

    >> Share

    
    
24. MURPHY C, Dyer AH, Lawlor B, Kennelly SP, et al
    What is the impact of ongoing statin use on cognitive decline and dementia progression in older adults with mild-moderate Alzheimer disease?
    PLoS One. 2023;18:e0285529.
    

    >> Share

    
    
25. GATTO RG, Carlos AF, Reichard RR, Lowe VJ, et al
    Comparative assessment of regional tau distribution by Tau-PET and Post-mortem neuropathology in a representative set of Alzheimer's & frontotemporal lobar degeneration patients.
    PLoS One. 2023;18:e0284182.
    

    >> Share

    
    
26. FARINA MP, Saenz J, Crimmins EM
    Does adding MRI and CSF-based biomarkers improve cognitive status classification based on cognitive performance questionnaires?
    PLoS One. 2023;18:e0285220.
    

    >> Share

    
    
27. TAULE T, Eide IS, Fjaer L, Myrberget MA, et al
    Norwegian version of the Edinburgh cognitive and behavioural ALS screen: Construct validity, internal consistency, inter-rater, and test-retest reliability.
    PLoS One. 2023;18:e0285307.
    

    >> Share

    
    
28. JEMIMAH S, Chabib CMM, Hadjileontiadis L, AlShehhi A, et al
    Gut microbiome dysbiosis in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0285346.
    

    >> Share

    
    January 2022
29. KIM HJ, Ryou JH, Choi KT, Kim SM, et al
    Deficits in color detection in patients with Alzheimer disease.
    PLoS One. 2022;17:e0262226.
    

    >> Share

    
    
30. SHABBIR U, Tyagi A, Ham HJ, Oh DH, et al
    Comprehensive profiling of bioactive compounds in germinated black soybeans via UHPLC-ESI-QTOF-MS/MS and their anti-Alzheimer's activity.
    PLoS One. 2022;17:e0263274.
    

    >> Share

    
    
31. LEACH JM, Edwards LJ, Kana R, Visscher K, et al
    The spike-and-slab elastic net as a classification tool in Alzheimer's disease.
    PLoS One. 2022;17:e0262367.
    

    >> Share

    
    
32. JUNG NY, Kim HS, Kim ES, Jeon S, et al
    Serum progranulin is not associated with rs5848 polymorphism in Korean patients with neurodegenerative diseases.
    PLoS One. 2022;17:e0261007.
    

    >> Share

    
    
33. HUANG YC, Hsu SM, Shie FS, Shiao YJ, et al
    Reduced mitochondria membrane potential and lysosomal acidification are associated with decreased oligomeric Abeta degradation induced by hyperglycemia: A study of mixed glia cultures.
    PLoS One. 2022;17:e0260966.
    

    >> Share

    
    
34. QUERFURTH H, Marshall J, Parang K, Rioult-Pedotti MS, et al
    A PDK-1 allosteric agonist neutralizes insulin signaling derangements and beta-amyloid toxicity in neuronal cells and in vitro.
    PLoS One. 2022;17:e0261696.
    

    >> Share

    
    
35. LEE JI, Lim JS, Hong JH, Kim S, et al
    Selective neurodegeneration of the hippocampus caused by chronic cerebral hypoperfusion: F-18 FDG PET study in rats.
    PLoS One. 2022;17:e0262224.
    

    >> Share

    
    
36. SADLEIR KR, Popovic J, Khatri A, Vassar R, et al
    Oral nimodipine treatment has no effect on amyloid pathology or neuritic dystrophy in the 5XFAD mouse model of amyloidosis.
    PLoS One. 2022;17:e0263332.
    

    >> Share

    
    
37. REHMAN S, Ali Ashfaq U, Sufyan M, Shahid I, et al
    The Insight of In Silico and In Vitro evaluation of Beta vulgaris phytochemicals against Alzheimer's disease targeting acetylcholinesterase.
    PLoS One. 2022;17:e0264074.
    

    >> Share

    
    
38. SUZUKI Y, Suzuki M, Shigenobu K, Shinosaki K, et al
    A prospective multicenter validation study of a machine learning algorithm classifier on quantitative electroencephalogram for differentiating between dementia with Lewy bodies and Alzheimer's dementia.
    PLoS One. 2022;17:e0265484.
    

    >> Share

    
    
39. ZHANG Q, Yang X, Sun Z
    Classification of Alzheimer's disease progression based on sMRI using gray matter volume and lateralization index.
    PLoS One. 2022;17:e0262722.
    

    >> Share

    
    
40. MARTIZ RM, Patil SM, Ramu R, M K J, et al
    Discovery of novel benzophenone integrated derivatives as anti-Alzheimer's agents targeting presenilin-1 and presenilin-2 inhibition: A computational approach.
    PLoS One. 2022;17:e0265022.
    

    >> Share

    
    
41. PAYNE M, Manera V, Robert P, Vandersteen C, et al
    Olfactory identification disorders due to Alzheimer's disease: A new test from France to Quebec.
    PLoS One. 2022;17:e0265764.
    

    >> Share

    
    
42. IOHAN LDCC, Lambert JC, Costa MR
    Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer's disease and progressive supranuclear palsy.
    PLoS One. 2022;17:e0266405.
    

    >> Share

    
    
43. SARIS IMJ, Aghajani M, Jongs N, Reus LM, et al
    Cross-disorder and disorder-specific deficits in social functioning among schizophrenia and alzheimer's disease patients.
    PLoS One. 2022;17:e0263769.
    

    >> Share

    
    
44. MOUSA D, Zayed N, Yassine IA
    Alzheimer disease stages identification based on correlation transfer function system using resting-state functional magnetic resonance imaging.
    PLoS One. 2022;17:e0264710.
    

    >> Share

    
    
45. KORTHAUER LE, Giugliano RP, Guo J, Sabatine MS, et al
    No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab.
    PLoS One. 2022;17:e0266615.
    

    >> Share

    
    
46. YOUSEFZADEH-NOWSHAHR E, Winter G, Bohn P, Kneer K, et al
    Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical setting.
    PLoS One. 2022;17:e0266906.
    

    >> Share

    
    
47. UCHIYAMA S, Kamoi F, Tanaka M, Joko I, et al
    What is the subtype of dementia in patients with fragility hip fracture?
    PLoS One. 2022;17:e0265636.
    

    >> Share

    
    
48. ABD EL-RAHMAN SS, Fayed HM
    Improved cognition impairment by activating cannabinoid receptor type 2: Modulating CREB/BDNF expression and impeding TLR-4/NFkappaBp65/M1 microglia signaling pathway in D-galactose-injected ovariectomized rats.
    PLoS One. 2022;17:e0265961.
    

    >> Share

    
    
49. SOLIMAN MG, Davies HA, Sharkey J, Levy R, et al
    Development of amyloid beta gold nanorod aggregates as optoacoustic probes.
    PLoS One. 2022;17:e0259608.
    

    >> Share

    
    
50. BANACK SA, Stark AC, Cox PA
    A possible blood plasma biomarker for early-stage Alzheimer's disease.
    PLoS One. 2022;17:e0267407.
    

    >> Share

    
    
51. NAITO N, Hirosawa T, Tsubomoto M, Miyagishi Y, et al
    Prominent gamma band activity during visual motion perception in early-stage Alzheimer's disease.
    PLoS One. 2022;17:e0266693.
    

    >> Share

    
    
52. SOUDY R, Kimura R, Fu W, Patel A, et al
    Extracellular vesicles enriched with amylin receptor are cytoprotective against the Ass toxicity in vitro.
    PLoS One. 2022;17:e0267164.
    

    >> Share

    
    
53. HERNANDEZ M, Ramon-Julvez U, Ferraz F
    Explainable AI toward understanding the performance of the top three TADPOLE Challenge methods in the forecast of Alzheimer's disease diagnosis.
    PLoS One. 2022;17:e0264695.
    

    >> Share

    
    
54. PHAM H, Yin T, D'Adamio L
    Initial assessment of the spatial learning, reversal, and sequencing task capabilities of knock-in rats with humanizing mutations in the Abeta-coding region of App.
    PLoS One. 2022;17:e0263546.
    

    >> Share

    
    
55. ANDRADE JM, Pachar P, Trujillo L, Cartuche L, et al
    Suillin: A mixed-type acetylcholinesterase inhibitor from Suillus luteus which is used by Saraguros indigenous, southern Ecuador.
    PLoS One. 2022;17:e0268292.
    

    >> Share

    
    
56. CANNAVO C, Cleverley K, Maduro C, Mumford P, et al
    Endosomal structure and APP biology are not altered in a preclinical mouse cellular model of Down syndrome.
    PLoS One. 2022;17:e0262558.
    

    >> Share

    
    
57. ALI M, Sung YJ, Wang F, Fernandez MV, et al
    Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk.
    PLoS One. 2022;17:e0267298.
    

    >> Share

    
    
58. GARCIA MARIN ID, Camarillo Lopez RH, Martinez OA, Padilla-Martinez II, et al
    New compounds from heterocyclic amines scaffold with multitarget inhibitory activity on Abeta aggregation, AChE, and BACE1 in the Alzheimer disease.
    PLoS One. 2022;17:e0269129.
    

    >> Share

    
    
59. SELF W, Awwad K, Savaryn JP, Schulz M, et al
    An immuno-enrichment free, validated quantification of tau protein in human CSF by LC-MS/MS.
    PLoS One. 2022;17:e0269157.
    

    >> Share

    
    
60. ZAMANI J, Sadr A, Javadi AH
    Classification of early-MCI patients from healthy controls using evolutionary optimization of graph measures of resting-state fMRI, for the Alzheimer's disease neuroimaging initiative.
    PLoS One. 2022;17:e0267608.
    

    >> Share

    
    
61. LEE H, Kim HK, Kim B, Han K, et al
    Augmented risk of dementia in hypertrophic cardiomyopathy: A propensity score matching analysis using the nationwide cohort.
    PLoS One. 2022;17:e0269911.
    

    >> Share

    
    
62. FLO BK, Matziorinis AM, Skouras S, Sudmann TT, et al
    Study protocol for the Alzheimer and music therapy study: An RCT to compare the efficacy of music therapy and physical activity on brain plasticity, depressive symptoms, and cognitive decline, in a population with and at risk for Alzheimer's disease.
    PLoS One. 2022;17:e0270682.
    

    >> Share

    
    
63. ALI SK, Ali RH
    Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin.
    PLoS One. 2022;17:e0271138.
    

    >> Share

    
    
64. CUADRADO F, Antoli A, Fernandez-Calvo B
    The effect of framing on attitudes towards Alzheimer's disease. A comparative study between younger and older adults.
    PLoS One. 2022;17:e0270959.
    

    >> Share

    
    
65. KANNAPPAN B, Gunasekaran TI, Te Nijenhuis J, Gopal M, et al
    Polygenic score for Alzheimer's disease identifies differential atrophy in hippocampal subfield volumes.
    PLoS One. 2022;17:e0270795.
    

    >> Share

    
    
66. VIDONI ED, Morris JK, Palmer JA, Li Y, et al
    Dementia risk and dynamic response to exercise: A non-randomized clinical trial.
    PLoS One. 2022;17:e0265860.
    

    >> Share

    
    
67. KHASAWNEH RR, Abu-El-Rub E, Alzu'bi A, Abdelhady GT, et al
    Corpus callosum anatomical changes in Alzheimer patients and the effect of acetylcholinesterase inhibitors on corpus callosum morphometry.
    PLoS One. 2022;17:e0269082.
    

    >> Share

    
    
68. BAJIC VP, Salhi A, Lakota K, Radovanovic A, et al
    DES-Amyloidoses "Amyloidoses through the looking-glass": A knowledgebase developed for exploring and linking information related to human amyloid-related diseases.
    PLoS One. 2022;17:e0271737.
    

    >> Share

    
    
69. BRAIN J, Tully PJ, Turnbull D, Tang E, et al
    Risk factors for dementia in the context of cardiovascular disease: A protocol of an overview of reviews.
    PLoS One. 2022;17:e0271611.
    

    >> Share

    
    
70. TEJADA MORENO JA, Villegas Lanau A, Madrigal Zapata L, Baena Pineda AY, et al
    Mutations in SORL1 and MTHFDL1 possibly contribute to the development of Alzheimer's disease in a multigenerational Colombian Family.
    PLoS One. 2022;17:e0269955.
    

    >> Share

    
    
71. SINCLAIR P, Kabbani N
    Nicotinic receptor components of amyloid beta 42 proteome regulation in human neural cells.
    PLoS One. 2022;17:e0270479.
    

    >> Share

    
    
72. FAVERO F, Barberis E, Gagliardi M, Espinoza S, et al
    A Metabologenomic approach reveals alterations in the gut microbiota of a mouse model of Alzheimer's disease.
    PLoS One. 2022;17:e0273036.
    

    >> Share

    
    
73. ACQUARELLI J, van Laarhoven T, Postma GJ, Jansen JJ, et al
    Convolutional neural networks to predict brain tumor grades and Alzheimer's disease with MR spectroscopic imaging data.
    PLoS One. 2022;17:e0268881.
    

    >> Share

    
    
74. NAMCHAIW P, Bunreangsri P, Eiamcharoen P, Eiamboonsert S, et al
    An in vitro workflow of neuron-laden agarose-laminin hydrogel for studying small molecule-induced amyloidogenic condition.
    PLoS One. 2022;17:e0273458.
    

    >> Share

    
    
75. FANG Y, Doyle MF, Chen J, Alosco ML, et al
    Association between inflammatory biomarkers and cognitive aging.
    PLoS One. 2022;17:e0274350.
    

    >> Share

    
    
76. HLYNIALUK C, Kemper L, Leinonen-Wright K, Petersen RC, et al
    Caspase-2 mRNA levels are not elevated in mild cognitive impairment, Alzheimer's disease, Huntington's disease, or Lewy Body dementia.
    PLoS One. 2022;17:e0274784.
    

    >> Share

    
    
77. WEI Y, Heun-Johnson H, Tysinger B
    Using dynamic microsimulation to project cognitive function in the elderly population.
    PLoS One. 2022;17:e0274417.
    

    >> Share

    
    
78. HOHBERGER B, Pruss H, Mardin C, Lammer R, et al
    Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance.
    PLoS One. 2022;17:e0272811.
    

    >> Share

    
    
79. SUGIOKA J, Suzumura S, Kuno K, Kizuka S, et al
    Relationship between finger movement characteristics and brain voxel-based morphometry.
    PLoS One. 2022;17:e0269351.
    

    >> Share

    
    
80. WONG J, Steyn JS, Pienaar IS, Elson JL, et al
    Mitochondrial DNA population variation is not associated with Alzheimer's in the Japanese population: A consistent finding across global populations.
    PLoS One. 2022;17:e0276169.
    

    >> Share

    
    
81. SU S, Esparza TJ, Brody DL
    Selection of single domain anti-transferrin receptor antibodies for blood-brain barrier transcytosis using a neurotensin based assay and histological assessment of target engagement in a mouse model of Alzheimer's related amyloid-beta pathology.
    PLoS One. 2022;17:e0276107.
    

    >> Share

    
    
82. KANNAPPAN B, Te Nijenhuis J, Choi YY, Lee JJ, et al
    Can hippocampal subfield measures supply information that could be used to improve the diagnosis of Alzheimer's disease?
    PLoS One. 2022;17:e0275233.
    

    >> Share

    
    
83. NASIRI M, Moayedfar S, Purmohammad M, Ghasisin L, et al
    Investigating sentence processing and working memory in patients with mild Alzheimer and elderly people.
    PLoS One. 2022;17:e0266552.
    

    >> Share

    
    
84. ZARETSKY DV, Zaretskaia MV, Molkov YI
    Patients with Alzheimer's disease have an increased removal rate of soluble beta-amyloid-42.
    PLoS One. 2022;17:e0276933.
    

    >> Share

    
    
85. RANTS'O TA, van Greunen DG, van der Westhuizen CJ, Riley DL, et al
    The in silico and in vitro analysis of donepezil derivatives for Anopheles acetylcholinesterase inhibition.
    PLoS One. 2022;17:e0277363.
    

    >> Share

    
    
86. TOLEDO JB, Rashid T, Liu H, Launer L, et al
    SPARE-Tau: A flortaucipir machine-learning derived early predictor of cognitive decline.
    PLoS One. 2022;17:e0276392.
    

    >> Share

    
    
87. KARAMAN BK, Mormino EC, Sabuncu MR
    Machine learning based multi-modal prediction of future decline toward Alzheimer's disease: An empirical study.
    PLoS One. 2022;17:e0277322.
    

    >> Share

    
    
88. BARTELS SL, Shaaban CE, Brum WS, Welikovitch LA, et al
    Impact of the COVID-19 pandemic on early career dementia researchers: A global online survey.
    PLoS One. 2022;17:e0277470.
    

    >> Share

    
    
89. CHAN D, Suk HJ, Jackson BL, Milman NP, et al
    Gamma frequency sensory stimulation in mild probable Alzheimer's dementia patients: Results of feasibility and pilot studies.
    PLoS One. 2022;17:e0278412.
    

    >> Share

    
    
90. JUNG JH, Kim G, Byun MS, Lee JH, et al
    Gut microbiome alterations in preclinical Alzheimer's disease.
    PLoS One. 2022;17:e0278276.
    

    >> Share

    
    
91. XIA W, Gao Z, Jiang X, Jiang L, et al
    Alzheimer's risk factor FERMT2 promotes the progression of colorectal carcinoma via Wnt/beta-catenin signaling pathway and contributes to the negative correlation between Alzheimer and cancer.
    PLoS One. 2022;17:e0278774.
    

    >> Share

    
    
92. MAFI JN, Walling AM, Villaflores C, Vangala S, et al
    A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer's and related dementias.
    PLoS One. 2022;17:e0277409.
    

    >> Share

    
    
93. OIZUMI H, Sugimura Y, Totsune T, Kawasaki I, et al
    Plasma sphingolipid abnormalities in neurodegenerative diseases.
    PLoS One. 2022;17:e0279315.
    

    >> Share

    
    
94. MCCARTHY MM, Hardy MJ, Leising SE, LaFollette AM, et al
    An amino-terminal fragment of apolipoprotein E4 leads to behavioral deficits, increased PHF-1 immunoreactivity, and mortality in zebrafish.
    PLoS One. 2022;17:e0271707.
    

    >> Share

    
    
95. CARDOEN B, Wong T, Alan P, Lee S, et al
    SPECHT: Self-tuning Plausibility based object detection Enables quantification of Conflict in Heterogeneous multi-scale microscopy.
    PLoS One. 2022;17:e0276726.
    

    >> Share

    
    January 2021
96. PENNER G, Lecocq S, Chopin A, Vedoya X, et al
    Aptamarker prediction of brain amyloid-beta status in cognitively normal individuals at risk for Alzheimer's disease.
    PLoS One. 2021;16:e0243902.
    

    >> Share

    
    
97. VIDONI ED, Morris JK, Watts A, Perry M, et al
    Effect of aerobic exercise on amyloid accumulation in preclinical Alzheimer's: A 1-year randomized controlled trial.
    PLoS One. 2021;16:e0244893.
    

    >> Share

    
    
98. MEGHDADI AH, Stevanovic Karic M, McConnell M, Rupp G, et al
    Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment.
    PLoS One. 2021;16:e0244180.
    

    >> Share

    
    
99. TOKUMITSU K, Yasui-Furukori N, Takeuchi J, Yachimori K, et al
    The combination of MMSE with VSRAD and eZIS has greater accuracy for discriminating mild cognitive impairment from early Alzheimer's disease than MMSE alone.
    PLoS One. 2021;16:e0247427.
    

    >> Share

    
    
100. CHELLAPPA RC, Lukose B, Rani P
     Correction: G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology.
     PLoS One. 2021;16:e0248252.
     

     >> Share

     
     
101. VOIGT RM, Raeisi S, Yang J, Leurgans S, et al
     Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer's disease.
     PLoS One. 2021;16:e0240342.
     

     >> Share

     
     
102. GJERUM L, Andersen BB, Bruun M, Simonsen AH, et al
     Comparison of the clinical impact of 2-[18F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer's disease.
     PLoS One. 2021;16:e0248413.
     

     >> Share

     
     
103. ZABEL P, Kaluzny JJ, Zabel K, Kaluzna M, et al
     Quantitative assessment of retinal thickness and vessel density using optical coherence tomography angiography in patients with Alzheimer's disease and glaucoma.
     PLoS One. 2021;16:e0248284.
     

     >> Share

     
     
104. BAHADO-SINGH RO, Vishweswaraiah S, Aydas B, Yilmaz A, et al
     Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer's disease.
     PLoS One. 2021;16:e0248375.
     

     >> Share

     
     
105. KIM D, Lee JH, Kim HY, Shin J, et al
     Correction: Fluorescent indolizine derivative YI-13 detects amyloid-beta monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model.
     PLoS One. 2021;16:e0250194.
     

     >> Share

     
     
106. TSUNEISHI M, Yamamoto T, Yamaguchi T, Kodama T, et al
     Association between number of teeth and Alzheimer's disease using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
     PLoS One. 2021;16:e0251056.
     

     >> Share

     
     
107. VELAZQUEZ M, Lee Y
     Random forest model for feature-based Alzheimer's disease conversion prediction from early mild cognitive impairment subjects.
     PLoS One. 2021;16:e0244773.
     

     >> Share

     
     
108. MCCORMICK JW, Ammerman L, Chen G, Vogel PD, et al
     Transport of Alzheimer's associated amyloid-beta catalyzed by P-glycoprotein.
     PLoS One. 2021;16:e0250371.
     

     >> Share

     
     
109. WEN LY, Wan L, Lai JN, Chen CS, et al
     Increased risk of Alzheimer's disease among patients with age-related macular degeneration: A nationwide population-based study.
     PLoS One. 2021;16:e0250440.
     

     >> Share

     
     
110. STOJANOVIC F, Taktek M, Khieu NH, Huang J, et al
     NMR analysis of the correlation of metabolic changes in blood and cerebrospinal fluid in Alzheimer model male and female mice.
     PLoS One. 2021;16:e0250568.
     

     >> Share

     
     
111. ZHENG C, Xu R
     Molecular subtyping of Alzheimer's disease with consensus non-negative matrix factorization.
     PLoS One. 2021;16:e0250278.
     

     >> Share

     
     
112. JIANG X, Howard JH Jr, Rebeck GW, Turner RS, et al
     Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer's disease.
     PLoS One. 2021;16:e0252958.
     

     >> Share

     
     
113. ZHANG J, Zhang Y, Zou J, Cao F, et al
     A meta-analysis of cohort studies: Traumatic brain injury and risk of Alzheimer's Disease.
     PLoS One. 2021;16:e0253206.
     

     >> Share

     
     
114. FUKUI K, Kimura S, Kato Y, Kohno M, et al
     Effects of far infrared light on Alzheimer's disease-transgenic mice.
     PLoS One. 2021;16:e0253320.
     

     >> Share

     
     
115. WENG J, Zhao G, Weng L, Guan J, et al
     Aspirin using was associated with slower cognitive decline in patients with Alzheimer's disease.
     PLoS One. 2021;16:e0252969.
     

     >> Share

     
     
116. MINICUCCI J, Alfond M, Demuro A, Gerberry D, et al
     Quantifying the dose-dependent impact of intracellular amyloid beta in a mathematical model of calcium regulation in xenopus oocyte.
     PLoS One. 2021;16:e0246116.
     

     >> Share

     
     
117. TOPPING M, Kim J, Fletcher J
     Geographic variation in Alzheimer's disease mortality.
     PLoS One. 2021;16:e0254174.
     

     >> Share

     
     
118. RHEW SH, Kravchenko J, Lyerly HK
     Exposure to low-dose ambient fine particulate matter PM2.5 and Alzheimer's disease, non-Alzheimer's dementia, and Parkinson's disease in North Carolina.
     PLoS One. 2021;16:e0253253.
     

     >> Share

     
     
119. LIBOWITZ MR, Wei K, Tran T, Chu K, et al
     Regional brain volumes relate to Alzheimer's disease cerebrospinal fluid biomarkers and neuropsychometry: A cross-sectional, observational study.
     PLoS One. 2021;16:e0254332.
     

     >> Share

     
     
120. HUI J, Zhao Y, Yu S, Liu J, et al
     Detection of retinal changes with optical coherence tomography angiography in mild cognitive impairment and Alzheimer's disease patients: A meta-analysis.
     PLoS One. 2021;16:e0255362.
     

     >> Share

     
     
121. LEE SH, Chen YH, Chien CC, Yan YH, et al
     Three month inhalation exposure to low-level PM2.5 induced brain toxicity in an Alzheimer's disease mouse model.
     PLoS One. 2021;16:e0254587.
     

     >> Share

     
     
122. SAKUTA S, Hashimoto M, Ikeda M, Koyama A, et al
     Clinical features of behavioral symptoms in patients with semantic dementia: Does semantic dementia cause autistic traits?
     PLoS One. 2021;16:e0247184.
     

     >> Share

     
     
123. PIERSSON AD, Ibrahim B, Suppiah S, Mohamad M, et al
     Multiparametric MRI for the improved diagnostic accuracy of Alzheimer's disease and mild cognitive impairment: Research protocol of a case-control study design.
     PLoS One. 2021;16:e0252883.
     

     >> Share

     
     
124. WICKLAND DP, Ren Y, Sinnwell JP, Reddy JS, et al
     Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studies.
     PLoS One. 2021;16:e0249305.
     

     >> Share

     
     
125. VESPA A, Spatuzzi R, Fabbietti P, Penna M, et al
     Association between care burden, depression and personality traits in Alzheimer's caregiver: A pilot study.
     PLoS One. 2021;16:e0251813.
     

     >> Share

     
     
126. BARTL M, Dakna M, Galasko D, Hutten SJ, et al
     Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.
     PLoS One. 2021;16:e0257372.
     

     >> Share

     
     
127. KOLINGER GD, Vallez Garcia D, Willemsen ATM, Reesink FE, et al
     Amyloid burden quantification depends on PET and MR image processing methodology.
     PLoS One. 2021;16:e0248122.
     

     >> Share

     
     
128. FERNANDEZ-BLAZQUEZ MA, Del Ser T, Frades-Payo B, Avila-Villanueva M, et al
     MADRID+90 study on factors associated with longevity: Study design and preliminary data.
     PLoS One. 2021;16:e0251796.
     

     >> Share

     
     
129. CALDERON C, Beyle C, Veliz-Garcia O, Bekios-Calfa J, et al
     Psychometric properties of Addenbrooke's Cognitive Examination III (ACE-III): An item response theory approach.
     PLoS One. 2021;16:e0251137.
     

     >> Share

     
     
130. AKBOR MM, Kurosawa N, Nakayama H, Nakatani A, et al
     Polymorphic SERPINA3 prolongs oligomeric state of amyloid beta.
     PLoS One. 2021;16:e0248027.
     

     >> Share

     
     
131. PARWEEN F, Hossain MS, Singh KP, Gupta RD, et al
     Association between human paraoxonase 2 protein and efficacy of acetylcholinesterase inhibiting drugs used against Alzheimer's disease.
     PLoS One. 2021;16:e0258879.
     

     >> Share

     
     
132. NOGUCHI-SHINOHARA M, Koike M, Morise H, Kudo K, et al
     MEG activity of the dorsolateral prefrontal cortex during optic flow stimulations detects mild cognitive impairment due to Alzheimer's disease.
     PLoS One. 2021;16:e0259677.
     

     >> Share

     
     
133. BAILEY DK, Clark W, Kosman DJ
     The iron chelator, PBT434, modulates transcellular iron trafficking in brain microvascular endothelial cells.
     PLoS One. 2021;16:e0254794.
     

     >> Share

     
     
134. WU Y, Whittaker HT, Noy S, Cleverley K, et al
     The effects of Cstb duplication on APP/amyloid-beta pathology and cathepsin B activity in a mouse model.
     PLoS One. 2021;16:e0242236.
     

     >> Share

     
     
135. JIANG H, Esparza TJ, Kummer TT, Brody DL, et al
     Unbiased high-content screening reveals Abeta- and tau-independent synaptotoxic activities in human brain homogenates from Alzheimer's patients and high-pathology controls.
     PLoS One. 2021;16:e0259335.
     

     >> Share

     
     
136. JIANG J, Liu H, Wang Z, Tian H, et al
     Electroacupuncture could balance the gut microbiota and improve the learning and memory abilities of Alzheimer's disease animal model.
     PLoS One. 2021;16:e0259530.
     

     >> Share

     
     
137. CZAPSKI GA, Cieslik M, Bialopiotrowicz E, Lukiw WJ, et al
     Down-regulation of cyclin D2 in amyloid beta toxicity, inflammation, and Alzheimer's disease.
     PLoS One. 2021;16:e0259740.
     

     >> Share

     
     
138. GRUNDMAN J, Spencer B, Sarsoza F, Rissman RA, et al
     Transcriptome analyses reveal tau isoform-driven changes in transposable element and gene expression.
     PLoS One. 2021;16:e0251611.
     

     >> Share

     
     
139. WU X, Peng C, Nelson PT, Cheng Q, et al
     Random forest-integrated analysis in AD and LATE brain transcriptome-wide data to identify disease-specific gene expression.
     PLoS One. 2021;16:e0256648.
     

     >> Share

     
     
140. SHIMODA A, Li Y, Hayashi H, Kondo N, et al
     Dementia risks identified by vocal features via telephone conversations: A novel machine learning prediction model.
     PLoS One. 2021;16:e0253988.
     

     >> Share

     
     
141. XIN XY, Lai ZH, Ding KQ, Zeng LL, et al
     Angiotensin-converting enzyme polymorphisms AND Alzheimer's disease susceptibility: An updated meta-analysis.
     PLoS One. 2021;16:e0260498.
     

     >> Share

     
     
142. HIRALDO-GONZALEZ L, Trillo-Contreras JL, Garcia-Miranda P, Pineda-Sanchez R, et al
     Evaluation of aquaporins in the cerebrospinal fluid in patients with idiopathic normal pressure hydrocephalus.
     PLoS One. 2021;16:e0258165.
     

     >> Share

     
     
143. RICHARD P, Kozlowski L, Guillorit H, Garnier P, et al
     Queuine, a bacterial-derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration.
     PLoS One. 2021;16:e0253216.
     

     >> Share

     
     
144. SCHOBER J, Polina J, Walters F, Scott N, et al
     NNC 26-9100 increases Abeta1-42 phagocytosis, inhibits nitric oxide production and decreases calcium in BV2 microglia cells.
     PLoS One. 2021;16:e0254242.
     

     >> Share

     
     
145. KAMAL S, Park I, Kim YJ, Kim YJ, et al
     Alteration of the corpus callosum in patients with Alzheimer's disease: Deep learning-based assessment.
     PLoS One. 2021;16:e0259051.
     

     >> Share

     
     
146. ZUELKE AE, Riedel-Heller SG, Wittmann F, Pabst A, et al
     Gender-specific design and effectiveness of non-pharmacological interventions against cognitive decline and dementia-protocol for a systematic review and meta-analysis.
     PLoS One. 2021;16:e0256826.
     

     >> Share

     
     
147. KAYA-TILKI E, Dikmen M
     Neuroprotective effects of some epigenetic modifying drugs' on Chlamydia pneumoniae-induced neuroinflammation: A novel model.
     PLoS One. 2021;16:e0260633.
     

     >> Share

     
     January 2020
148. BOUBAKRI A, Leri M, Bucciantini M, Najjaa H, et al
     Allium roseum L. extract inhibits amyloid beta aggregation and toxicity involved in Alzheimer's disease.
     PLoS One. 2020;15:e0223815.
     

     >> Share

     
     
149. MITSUMORI R, Sakaguchi K, Shigemizu D, Mori T, et al
     Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM in the blood of Japanese Alzheimer's disease patients.
     PLoS One. 2020;15:e0239196.
     

     >> Share

     
     
150. RONCERO C, Nikelski J, Probst S, Fernandez A, et al
     The semantic storage loss score: An Algorithm for measuring an individual's level of semantic storage loss due to temporal lobe damage in neurodegenerative disease.
     PLoS One. 2020;15:e0235810.
     

     >> Share

     
     
151. GUPTA A, Kennedy K, Perales-Puchalt J, Drew D, et al
     Mild-moderate CKD is not associated with cognitive impairment in older adults in the Alzheimer's Disease Neuroimaging Initiative cohort.
     PLoS One. 2020;15:e0239871.
     

     >> Share

     
     
152. GAO Y, Sengupta A, Li M, Zu Z, et al
     Functional connectivity of white matter as a biomarker of cognitive decline in Alzheimer's disease.
     PLoS One. 2020;15:e0240513.
     

     >> Share

     
     
153. C RC, Lukose B, Rani P
     G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology.
     PLoS One. 2020;15:e0225487.
     

     >> Share

     
     
154. KUEPER JK, Lizotte DJ, Montero-Odasso M, Speechley M, et al
     Cognition and motor function: The gait and cognition pooled index.
     PLoS One. 2020;15:e0238690.
     

     >> Share

     
     
155. YAO T, Sweeney E, Nagorski J, Shulman JM, et al
     Quantifying cognitive resilience in Alzheimer's Disease: The Alzheimer's Disease Cognitive Resilience Score.
     PLoS One. 2020;15:e0241707.
     

     >> Share

     
     
156. YOKOSAWA K, Kimura K, Takase R, Murakami Y, et al
     Functional decline of the precuneus associated with mild cognitive impairment: Magnetoencephalographic observations.
     PLoS One. 2020;15:e0239577.
     

     >> Share

     
     
157. AHMED S, Kim BC, Lee KH, Jung HY, et al
     Ensemble of ROI-based convolutional neural network classifiers for staging the Alzheimer disease spectrum from magnetic resonance imaging.
     PLoS One. 2020;15:e0242712.
     

     >> Share

     
     
158. SEDGHIZADEH MJ, Hojjati H, Ezzatdoost K, Aghajan H, et al
     Olfactory response as a marker for Alzheimer's disease: Evidence from perceptual and frontal lobe oscillation coherence deficit.
     PLoS One. 2020;15:e0243535.
     

     >> Share

     
     
159. OKUDA M, Fujita Y, Takada-Takatori Y, Sugimoto H, et al
     Aromatherapy improves cognitive dysfunction in senescence-accelerated mouse prone 8 by reducing the level of amyloid beta and tau phosphorylation.
     PLoS One. 2020;15:e0240378.
     

     >> Share

     
     
160. GUYON A, Rousseau J, Lamothe G, Tremblay JP, et al
     The protective mutation A673T in amyloid precursor protein gene decreases Abeta peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cells.
     PLoS One. 2020;15:e0237122.
     

     >> Share

     
     
161. KIM D, Lee JH, Kim HY, Shin J, et al
     Fluorescent indolizine derivative YI-13 detects amyloid-beta monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model.
     PLoS One. 2020;15:e0243041.
     

     >> Share

     
     
162. DENG Y, Wu S, Fan H
     Genome-wide pathway-based quantitative multiple phenotypes analysis.
     PLoS One. 2020;15:e0240910.
     

     >> Share

     
     
163. LI QS, Tian C, Hinds D, Seabrook GR, et al
     The association of clinical phenotypes to known AD/FTD genetic risk loci and their inter-relationship.
     PLoS One. 2020;15:e0241552.
     

     >> Share

     
     
164. MENTINK LJ, Thomas J, Melis RJF, Olde Rikkert MGM, et al
     Home-EEG assessment of possible compensatory mechanisms for sleep disruption in highly irregular shift workers - The ANCHOR study.
     PLoS One. 2020;15:e0237622.
     

     >> Share

     
     
165. GREEN EH, Kikis EA
     Determining the effects of nanoparticulate air pollution on proteostasis in Caenorhabditis elegans.
     PLoS One. 2020;15:e0243419.
     

     >> Share

     
     
166. BORGSTEDT L, Blobner M, Musiol M, Bratke S, et al
     Neurotoxicity of different amyloid beta subspecies in mice and their interaction with isoflurane anaesthesia.
     PLoS One. 2020;15:e0242989.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share